子宫内膜癌的实用术前分子分型:以激素受体染色替代POLE测序
本研究对534例术前子宫内膜癌活检组织采用实用算法(激素受体、p53和错配修复蛋白染色,省略POLE测序)进行分子分型,并与505例采用传统算法(含POLE测序)的患者重叠比较。两种算法均识别出四个预后显著不同的组(p<0.001),但实用算法低风险组占44%,传统算法仅占7%。Cox分析显示实用算法预测疾病特异性生存更强,仅1.4%(7/498)患者未能被识别为潜在POLE驱动降阶梯治疗。
要点
- 术前ER、PR、MMR和p53染色可识别四个分子及预后组。
- 实用算法低风险组占44%,传统算法仅占7%。
- 实用算法预测DSS优于传统算法,仅1.4%患者漏检POLE降阶梯机会。
核心结论
- 术前评估ER、PR、MMR和p53可识别四个分子及预后组,实用分型可省略POLE测序。
- 作者提出的算法节省时间和资源,是完全分子分类的有价值替代方案。
研究设计与样本
- 术前子宫内膜癌活检组织分别按两种算法进行分子分型:实用算法含激素受体、p53和错配修复蛋白染色但不含POLE测序(n=534),传统算法含POLE测序且患者与实用队列完全重叠(n=505)。
- 采用Cox比例风险分析计算疾病特异性生存概率的风险比及95%置信区间。
主要发现
- 两种分类器均识别出四个预后显著不同的患者组(p<0.001)。
- 实用算法低风险组包含44%的患者,传统算法为7%。
- 术前Cox比例风险分析显示实用算法预测DSS强于传统算法。
- 实用算法仅1.4%(7/498)患者未能被识别为潜在POLE驱动降阶梯治疗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Molecular classification including POLE sequencing is encouraged for all endometrial cancer (EC) patients, although the relevance of POLE sequencing has been questioned. We aimed to determine whether POLE sequencing can be omitted when introducing hormone receptor (HR) immunohistochemical staining. METHODS: Preoperative EC biopsies were molecularly classified according to two different algorithms: a pragmatic approach including staining of HRs, p53 and mismatch repair (MMR) proteins but omitting POLE sequencing (n = 534), and the conventional algorithm including POLE sequencing and with patients completely overlapping with the pragmatic cohort (n = 505). The two algorithms were tested by Cox proportional hazard analysis calculating the probability of disease-specific survival (DSS) (hazard ratios) with 95 % confidence intervals. RESULTS: Both classifiers identified four patient groups with significantly different prognosis (p < 0.001). However, with the pragmatic approach, the group with lowest risk included 44 % of the patients, as compared to 7 % using the conventional algorithm. In the preoperative setting, Cox proportional hazard analysis demonstrated that the pragmatic algorithm was stronger to predict DSS than the conventional algorithm. Only 1.4 % (7/498) of patients failed to be identified for potential POLE-driven de-escalation of treatment using the pragmatic algorithm. CONCLUSIONS: Preoperative evaluation of ER, PR, MMR and p53 identifies four molecular and prognostic groups. This pragmatic classification allows POLE sequencing to be omitted. Our proposed algorithm saves time and resources and is a valuable alternative to full molecular classification.
引用
- Berg HF, Trovik J, Hjelmeland ME, et al. Pragmatic preoperative molecular classification of endometrial cancers; Replacing POLE sequencing with hormone receptor staining. Gynecol Oncol. 2025. PMID: 40398073. doi:10.1016/j.ygyno.2025.05.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。